Zhengyun Zou

State Key Laboratory Of Pharmaceutical Biotechnology
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Palmitic acid reprograms neutrophils to compromise vascular integrity and promote breast cancer lung metastasis.

Palmitic acid reprograms neutrophils to compromise vascular integrity and promote breast cancer lung metastasis.

Journal: Immunity

Published: February 18, 2026

Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Correction to: Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Journal: BMC cancer

Published: January 27, 2026

Characteristics of cancer mycobiome in patients with acral melanoma.

Characteristics of cancer mycobiome in patients with acral melanoma.

Journal: Journal for immunotherapy of cancer

Published: June 24, 2025

Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Recurrence risk prediction in resected stage I-III melanoma utilizing circulating tumor DNA.

Journal: BMC cancer

Published: June 08, 2025

Blocking CCR1+ macrophages overcomes resistance to immune checkpoint inhibitors in melanoma.

Blocking CCR1+ macrophages overcomes resistance to immune checkpoint inhibitors in melanoma.

Journal: Cell communication and signaling : CCS

Published: January 22, 2025

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade.

Journal: Cancer immunology, immunotherapy : CII

Published: January 19, 2025

Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma.

Tertiary lymphoid structures associated with improved survival and enhanced antitumor immunity in acral melanoma.

Journal: NPJ precision oncology

Published: September 25, 2024

Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.

Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.

Journal: Journal for immunotherapy of cancer

Published: March 29, 2024

Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma.

Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma.

Journal: Cancer immunology, immunotherapy : CII

Published: February 16, 2024

Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.

Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.

Journal: Journal of translational medicine

Published: November 04, 2022

Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma.

Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma.

Journal: Journal of cancer research and clinical oncology

Published: May 13, 2022

Jug-PLGA-NPs, a New Form of Juglone with Enhanced Efficiency and Reduced Toxicity on Melanoma.

Jug-PLGA-NPs, a New Form of Juglone with Enhanced Efficiency and Reduced Toxicity on Melanoma.

Journal: Chinese journal of integrative medicine

Published: June 11, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026